SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending amid speculation of a potential partnership with Tesla, fueled by suggestive social media activity, with the community actively discussing the implications of such a deal and its potential to ignite a short squeeze. Bullish sentiment is building as investors anticipate upcoming catalysts, including flight demonstrations and potential military contracts, while some debate the company's ability to compete with industry peers and achieve full VTOL capabilities. The stock's high short interest adds another layer of intrigue as traders weigh the potential for significant upside.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

QBTS is trending as part of a broader surge in quantum computing stocks, driven by interest in their potential to revolutionize industries and reduce energy consumption, especially for AI. Community discussions revolve around the high valuations of quantum companies relative to current revenue, with some cautioning against a potential bubble and others highlighting long-term growth potential. Some investors highlight the company's contracts and potential acquisitions as catalysts.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending due to a surge in interest in quantum computing stocks, with community members debating the sustainability of its high valuation relative to revenue. Some traders are pointing to potential short squeezes, while others highlight concerns about possible dilution and unsustainable growth. The stock's significant price movement and high volatility are contributing to the heightened discussion.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

QUBT is trending due to renewed interest in quantum computing stocks, with community members discussing the company's potential and comparing it to sector peers like RGTI and IONQ. Some traders are pointing to a recent private placement and potential government support as catalysts, while others express concerns about valuation and dilution. Overall, the conversation highlights the speculative nature of the sector and the debate between long-term potential and short-term risks.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending as it unveils AI partnerships with Nvidia, OpenAI, and Snowflake, exciting the community about its potential as a leader in enterprise AI automation. Discussions revolve around its shift from traditional RPA to 'Agentic AI,' with some seeing it as undervalued compared to peers like PLTR and SNOW. Despite positive news, some traders note struggles in holding gains, while others remain optimistic about long-term growth and potential rerating.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTX is trending as investors discuss a potential recovery after a significant drop, with community members pointing to strong underlying data and possible institutional manipulation as reasons for optimism. Discussions revolve around a large options purchase, fueling speculation about a potential buyout or upcoming positive news. Despite mixed sentiment, many believe the stock is oversold and poised for a rebound, citing a potentially promising drug pipeline.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community discusses potential exchange listings and partnerships, speculating on possible catalysts for significant price movement.  Many compare ZBCN to XRP in its early days, with some expressing long-term bullish sentiment and anticipating substantial gains. Chatter revolves around staking rewards, upcoming announcements, and the potential impact of regulatory compliance.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crypto asset CAW, also known as crow with knife, is trending due to community enthusiasm and repeated calls to "buy more." Community members are using the phrase "only option" to express confidence, while also highlighting its deflationary nature and strong community.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc ($TDOC) is trending as community members discuss a potential short squeeze and recent analyst activity, including bullish sentiment from Citron Research. Some investors believe the stock is undervalued, noting its cash flow and potential for growth in the telehealth sector, while others point to technical indicators suggesting a possible breakout. Community members are also speculating on potential catalysts such as a possible government shutdown or new contracts.

Fartcoin is a meme-driven cryptocurrency where users can submit their best fart jokes or memes to earn initial tokens. Each transaction triggers a hilarious 'Gas Fee' effect, complete with a digital fart sound for maximum comedic impact.

Fartcoin

$FARTCOIN is gaining attention, with community members highlighting its potential for growth and its connections to other Solana-based tokens like $UPDOG. Discussions revolve around its joke-meta status and potential for 'pumping,' while some traders analyze support and resistance levels for potential entry points. The community also notes links between FARTCOIN and other meme tokens, specifically the relationship with UpDog.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025 

GeneDx, Twist Bioscience and Wave Life Sciences are emerging as key players in the fast-growing genomics and synthetic biology space.

Why Is Allogene Therapeutics (ALLO) Up 9.4% Since Last Earnings Report?

Allogene Therapeutics (ALLO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Can CRSP's In Vivo Pipeline Aid Long-Term Growth Beyond Casgevy?

CRISPR Therapeutics pushes beyond Casgevy with in vivo programs like CTX310, CTX320 and plans for two more studies by 2025-end.

CRSP vs. BEAM: Which Gene Editing Stock Holds More Potential Right Now?

CRISPR Therapeutics gains momentum with Casgevy sales and a broader pipeline, while Beam Therapeutics advances base-editing therapies still in early stages.

CRISPR Therapeutics Gains 41.4% in 3 Months: How to Play the Stock

CRSP surges 41.4% in three months, fueled by promising CTX310 study data and accelerating Casgevy sales.

Can Rising Casgevy Sales Aid CRISPR Therapeutics Post Q2 Earnings?

CRSP's Casgevy records a 114% sales jump sequentially in Q2, fueling optimism for sustained revenues and long-term growth.

BEAM's Q2 Loss Narrower Than Expected, Revenues Miss Mark

Beam Therapeutics posts narrower second-quarter loss but misses revenue estimates. The company provides updates on pipeline progress.

Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Misses Revenue Estimates

Beam Therapeutics (BEAM) delivered earnings and revenue surprises of +3.85% and -38.59%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Vir Biotechnology, Inc. (VIR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Vir Biotechnology (VIR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 Genomics Stocks Worth Adding to Your Portfolio in 2025

CRISPR-based innovators like NTLA, EDIT and PRME are gaining traction as genomics reshapes the future of medicine and biotech

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.

Beam Therapeutics Inc

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

BEAM
Beam Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BEAM News

BEAM Beam Therapeutics Inc